These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1681376)

  • 21. Antibody to hepatitis C virus in German blood donors.
    Kühnl P; Seidl S; Stangel W; Beyer J; Sibrowski W; Flik J
    Lancet; 1989 Aug; 2(8658):324. PubMed ID: 2569115
    [No Abstract]   [Full Text] [Related]  

  • 22. Hepatitis C virus transmission by intravenous immunoglobulin.
    Farrugia A; Walker E
    Lancet; 1995 Aug; 346(8971):373; author reply 374-5. PubMed ID: 7542718
    [No Abstract]   [Full Text] [Related]  

  • 23. Hepatitis C virus transmission by intravenous immunoglobulin.
    James RC; Mosley JW
    Lancet; 1995 Aug; 346(8971):374; author reply 374-5. PubMed ID: 7542719
    [No Abstract]   [Full Text] [Related]  

  • 24. Risk factors for acute non-A, non-B hepatitis and their relationship to antibodies for hepatitis C virus: a case-control study.
    Mele A; Sagliocca L; Manzillo G; Converti F; Amoroso P; Stazi MA; Ferrigno L; Rapicetta M; Franco E; Adamo B
    Am J Public Health; 1994 Oct; 84(10):1640-3. PubMed ID: 7943485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies to hepatitis C virus.
    Roggendorf M; Deinhardt F; Rasshofer R; Eberle J; Hopf U; Möller B; Zachoval R; Pape G; Schramm W; Rommel F
    Lancet; 1989 Aug; 2(8658):324-5. PubMed ID: 2569116
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatitis C virus infection associated with administration of intravenous immune globulin. A cohort study.
    Bresee JS; Mast EE; Coleman PJ; Baron MJ; Schonberger LB; Alter MJ; Jonas MM; Yu MY; Renzi PM; Schneider LC
    JAMA; 1996 Nov; 276(19):1563-7. PubMed ID: 8918853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hepatitis C virus (HCV), anti-HCV and non-A, non-B hepatitis].
    Grob PJ; Joller-Jemelka HJ
    Schweiz Med Wochenschr; 1990 Feb; 120(5):117-24. PubMed ID: 2106158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus antibodies in haemodialysis patients.
    Lancet; 1990 Jun; 335(8702):1409-10. PubMed ID: 1971697
    [No Abstract]   [Full Text] [Related]  

  • 29. Transmission of hepatitis C virus in allografted patients: use of viral genotyping as an epidemiological marker.
    Gangneux JP; Traineau R; Tuveri R; Ravera N; Bureau C; Gluckman E; Benbunan M; Loiseau P
    Bone Marrow Transplant; 1996 Dec; 18(6):1131-3. PubMed ID: 8971383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sashima epidemic hepatitis: epidemiological feature and anti-HCV status].
    Wakayama Y; Aramaki T
    Nihon Rinsho; 1991 Feb; 49(2):397-401. PubMed ID: 1849199
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prevalence of anti-HCV (C100-3) antibodies in 20.373 blood donors].
    Zufferey C; Lavanchy D; Reiff M; Schneider P; Frei P; Pécoud A; Gonvers JJ
    Schweiz Med Wochenschr; 1992 Oct; 122(41):1524-9. PubMed ID: 1411411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous immunoglobulin plus interferon-alpha in autoimmune hepatitis C.
    Malaguarnera M; Guccione N; Musumeci S; Brogna A; Motta M; Di Fazio I
    BioDrugs; 2004; 18(1):63-70. PubMed ID: 14733608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C virus antibody positive blood donors.
    Mutimer D; Shaw J; Harrison R; Ala F; Neuberger J; Elias E
    Gut; 1993; 34(2 Suppl):S54. PubMed ID: 7686116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and significance of anti-HCV antibodies.
    De Groote J
    Acta Gastroenterol Belg; 1991; 54(3-4):248-56. PubMed ID: 1665270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hepatitis C antibodies in acute Non-A, Non-B hepatitis].
    Zellweger U; Havelka J; Zala G; Altorfer J; Joller-Jemelka HI; Schmid M; Bühler H
    Schweiz Med Wochenschr; 1991 May; 121(20):761-3. PubMed ID: 1711714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Failure to detect hepatitis C virus (HCV) genome by polymerase chain reaction in human anti-HCV-positive intravenous immunoglobulins.
    Dammacco F; Sansonno D; Beardsley A; Gowans EJ
    Clin Exp Immunol; 1993 May; 92(2):205-10. PubMed ID: 8387411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of hepatitis C in patients with primary antibody deficiency.
    Webster AD; Brown D; Franz A; Dusheiko G
    Clin Exp Immunol; 1996 Jan; 103(1):5-7. PubMed ID: 8565286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Will the real hepatitis C stand up?
    Lancet; 1989 Aug; 2(8658):307-8. PubMed ID: 2569106
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical and virologic features of hepatitis C virus infection associated with intravenous immunoglobulin.
    Jonas MM; Baron MJ; Bresee JS; Schneider LC
    Pediatrics; 1996 Aug; 98(2 Pt 1):211-5. PubMed ID: 8692620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of antibodies to hepatitis C virus in transfused children with cancer.
    Monteleone PM; Andrzejewski C; Kelleher JF
    Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):309-13. PubMed ID: 7978047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.